Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02530983 · ClinicalTrials.gov registry record
Mayo Clinic Upper Digestive Disease Survey
A clinical trial of Esophageal Cancer and Esophageal Neoplasms, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT02530983 is a study of Esophageal Cancer and Esophageal Neoplasms that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,000 participants, above the 491-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (104% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02530983, a study of Esophageal Cancer and Esophageal Neoplasms, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Mayo Clinic Conduit Report Card Questionnaires have been created in order to have a consistent evaluation tools for patients undergoing esophageal reconstruction or treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish the validation of the questionnaires/survey. Data will also lead to the establishment of "normal" or expected scores for patients undergoing each type of esophagectomy procedure and for upper digestive diseases. Data will contribute to creating treatment algorithms for symptom management for upper digestive diseases and for post-operative complications and symptoms as well as contribute to pre-operative education.
Conditions Studied
Interventions
- OTHER Mayo Clinic Upper Digestive Disease Survey on Paper
- OTHER Upper Digestive Disease (UDD Monitor) App
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2015-08 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02530983
The ClinicalTrials.gov registry entry for NCT02530983 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 491-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (104% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Mayo Clinic Upper Digestive Disease Survey on Paper is the first listed.
NCT02530983 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02530983 about?
NCT02530983 is a clinical study titled "Mayo Clinic Upper Digestive Disease Survey". The Mayo Clinic Conduit Report Card Questionnaires have been created in order to have a consistent evaluation tools for patients undergoing esophageal reconstruction or treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data ...
What is the current status of trial NCT02530983?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2015-08. Estimated completion is 2025-12.
What conditions does trial NCT02530983 study?
This clinical trial studies the following conditions: Esophageal Cancer, Esophageal Neoplasms, Esophagus Cancer, Esophagectomy, Cancer of the Esophagus.
What interventions are being tested in trial NCT02530983?
The interventions under investigation include: Mayo Clinic Upper Digestive Disease Survey on Paper (OTHER), Upper Digestive Disease (UDD Monitor) App (OTHER).
Who is sponsoring clinical trial NCT02530983?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02530983 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
-
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.